This study highlights Japanese-associated germline mutations among patients with BRCA1/2 wildtype HBOC syndrome and a strong family history, and provides evidence for the medical care of this high-risk population. The gene discussed is BRCA1; the disease is Hereditary breast and ovarian cancer syndrome.